Intra-Cellular Therapies(ITCI) - 2023 Q4 - Annual Results
Intra-Cellular Therapies(ITCI)2024-02-22 20:39
Exhibit 99.1 INTRA-CELLULAR THERAPIES REPORTS FOURTH QUARTER AND FULL-YEAR 2023 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Full year 2023 total revenues of 250.3 million in 2022 Full year 2023 CAPLYTA net product sales were 131.5 million, a 50% increase over the same period in 2022 In 2023, CAPLYTA total prescriptions achieved strong year-over-year growth of 85% ...